ZANDELISIB

UNII:	8Z28M5SX0X
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₁H₃₈F₂N₈O
Preferred Substance Name:	ZANDELISIB
InChIKey:	WPFUFWIHMYZXSF-UHFFFAOYSA-N
GSRS Full Record:	8Z28M5SX0X i

1401436-95-0
1,3,5-TRIAZIN-2-AMINE, 4-(2-(DIFLUOROMETHYL)-1H-BENZIMIDAZOL-1-YL)-N-(1,1-DIMETHYL-2-(2-(1-METHYL-4-PIPERIDINYL)PHENYL)ETHYL)-6-(4-MORPHOLINYL)-
4-(2-(DIFLUOROMETHYL)BENZIMIDAZOL-1-YL)-N-(1,1-DIMETHYL-2-(2-(1-METHYL-4-PIPERIDYL)PHENYL)ETHYL)-6-MORPHOLINO-1,3,5-TRIAZIN-2-AMINE
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine
ACC-524
ME-401
PW-143
PWT-143
PWT143
ZANDELISIB [JAN]
ZANDELISIB [USAN]
Zandelisib [WHO-DD]
zandelisib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZANDELISIB

Synonyms and Mappings

Resources